33.21
-0.54 (-1.6%)
-0.54 (-1.6%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 142,802 |
|
|||||
| News | - | ||||||
| Day High | 33.57 | Low High |
|||||
| Day Low | 32.95 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Eagle Pharmaceuticals Inc | EGRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.54 | -1.6% | 33.21 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 33.39 | 32.95 | 33.57 | 33.21 | 33.75 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,099 | 142,802 | $ 33.25 | $ 4,748,332 | - | 24.35 - 53.78 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:13:55 | formt | 57,415 | $ 33.21 | USD |
Period:
Draw Mode:
Eagle Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 432.26M | 13.02M | 6.96M | $ 171.55M | $ 18.42M | -0.66 | 20.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -461.00 | 14.30% |
Eagle Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EGRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 33.69 | 34.22 | 31.79 | 33.23 | 131,403 | -0.48 | -1.42% |
| 1 Month | 29.18 | 34.22 | 28.75 | 32.06 | 148,788 | 4.03 | 13.81% |
| 3 Months | 32.44 | 40.85 | 27.9701 | 32.87 | 153,637 | 0.77 | 2.37% |
| 6 Months | 39.76 | 43.586 | 24.35 | 32.04 | 165,211 | -6.55 | -16.47% |
| 1 Year | 44.95 | 53.78 | 24.35 | 38.30 | 149,353 | -11.74 | -26.12% |
| 3 Years | 55.74 | 59.115 | 24.35 | 43.52 | 140,386 | -22.53 | -40.42% |
| 5 Years | 61.63 | 85.66 | 24.35 | 50.42 | 161,667 | -28.42 | -46.11% |
Eagle Pharmaceuticals Description
| Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration. |